AVCRF
Price
$0.04
Change
+$0.02 (+100.00%)
Updated
Jun 27 closing price
Capitalization
12.03M
DSRLF
Price
$107.68
Change
-$0.98 (-0.90%)
Updated
Jun 20 closing price
Capitalization
5.99B
Interact to see
Advertisement

AVCRF vs DSRLF

Header iconAVCRF vs DSRLF Comparison
Open Charts AVCRF vs DSRLFBanner chart's image
Avricore Health
Price$0.04
Change+$0.02 (+100.00%)
Volume$1.5K
Capitalization12.03M
Diasorin S.R.L
Price$107.68
Change-$0.98 (-0.90%)
Volume$170
Capitalization5.99B
AVCRF vs DSRLF Comparison Chart in %
Loading...
AVCRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCRF vs. DSRLF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCRF is a Hold and DSRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AVCRF: $0.04 vs. DSRLF: $107.68)
Brand notoriety: AVCRF and DSRLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AVCRF: 2% vs. DSRLF: 72%
Market capitalization -- AVCRF: $12.03M vs. DSRLF: $5.99B
AVCRF [@Medical Specialties] is valued at $12.03M. DSRLF’s [@Medical Specialties] market capitalization is $5.99B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCRF’s FA Score shows that 0 FA rating(s) are green whileDSRLF’s FA Score has 1 green FA rating(s).

  • AVCRF’s FA Score: 0 green, 5 red.
  • DSRLF’s FA Score: 1 green, 4 red.
According to our system of comparison, DSRLF is a better buy in the long-term than AVCRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCRF’s TA Score shows that 1 TA indicator(s) are bullish while DSRLF’s TA Score has 4 bullish TA indicator(s).

  • AVCRF’s TA Score: 1 bullish, 6 bearish.
  • DSRLF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, DSRLF is a better buy in the short-term than AVCRF.

Price Growth

AVCRF (@Medical Specialties) experienced а -16.38% price change this week, while DSRLF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.34%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +2.73%.

Industries' Descriptions

@Medical Specialties (+2.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSRLF($5.99B) has a higher market cap than AVCRF($12M). DSRLF YTD gains are higher at: 0.773 vs. AVCRF (-13.043). DSRLF has higher annual earnings (EBITDA): 286M vs. AVCRF (-1.67M). DSRLF has more cash in the bank: 382M vs. AVCRF (2.29M). AVCRF has less debt than DSRLF: AVCRF (40K) vs DSRLF (1.37B). DSRLF has higher revenues than AVCRF: DSRLF (1.25B) vs AVCRF (28.7K).
AVCRFDSRLFAVCRF / DSRLF
Capitalization12M5.99B0%
EBITDA-1.67M286M-1%
Gain YTD-13.0430.773-1,688%
P/E RatioN/A27.32-
Revenue28.7K1.25B0%
Total Cash2.29M382M1%
Total Debt40K1.37B0%
FUNDAMENTALS RATINGS
AVCRF vs DSRLF: Fundamental Ratings
AVCRF
DSRLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
14
Undervalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
9762
PRICE GROWTH RATING
1..100
9054
P/E GROWTH RATING
1..100
10072
SEASONALITY SCORE
1..100
n/a11

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DSRLF's Valuation (14) in the null industry is in the same range as AVCRF (43). This means that DSRLF’s stock grew similarly to AVCRF’s over the last 12 months.

AVCRF's Profit vs Risk Rating (92) in the null industry is in the same range as DSRLF (100). This means that AVCRF’s stock grew similarly to DSRLF’s over the last 12 months.

DSRLF's SMR Rating (62) in the null industry is somewhat better than the same rating for AVCRF (97). This means that DSRLF’s stock grew somewhat faster than AVCRF’s over the last 12 months.

DSRLF's Price Growth Rating (54) in the null industry is somewhat better than the same rating for AVCRF (90). This means that DSRLF’s stock grew somewhat faster than AVCRF’s over the last 12 months.

DSRLF's P/E Growth Rating (72) in the null industry is in the same range as AVCRF (100). This means that DSRLF’s stock grew similarly to AVCRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVCRFDSRLF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
43%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
30%
MACD
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
34%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
31%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
AVCRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FELC34.300.20
+0.59%
Fidelity Enhanced Large Cap Core ETF
FTXG22.040.05
+0.23%
First Trust Nasdaq Food & Beverage ETF
THNR22.700.04
+0.18%
Amplify Weight Loss Drug & Treatment ETF
AVXC56.35-0.03
-0.06%
Avantis Emerging Markets Ex-Chn Eq ETF
PALL103.53-0.38
-0.37%
abrdn Physical Palladium Shares ETF

AVCRF and

Correlation & Price change

A.I.dvisor tells us that AVCRF and VMTHF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCRF and VMTHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCRF
1D Price
Change %
AVCRF100%
+111.76%
VMTHF - AVCRF
23%
Poorly correlated
N/A
TMCI - AVCRF
21%
Poorly correlated
+2.86%
JMPHF - AVCRF
20%
Poorly correlated
N/A
INSP - AVCRF
20%
Poorly correlated
+2.08%
RPID - AVCRF
20%
Poorly correlated
+2.87%
More

DSRLF and

Correlation & Price change

A.I.dvisor tells us that DSRLF and TWST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DSRLF and TWST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSRLF
1D Price
Change %
DSRLF100%
N/A
TWST - DSRLF
28%
Poorly correlated
-2.73%
LMAT - DSRLF
26%
Poorly correlated
+0.21%
LUNG - DSRLF
21%
Poorly correlated
+0.39%
AVCRF - DSRLF
20%
Poorly correlated
+111.76%
CNVVY - DSRLF
16%
Poorly correlated
-2.18%
More